Sg Americas Securities, LLC Curis Inc Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$2.31 - $5.13 $38,082 - $84,573	-16,486 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$4.45 - $8.09 $86,200 - $156,711	-19,371 Reduced 54.02%	16,486 $78,000
Q3 2021 Nov 01, 2021	BUY	$6.94 - $8.85 $248,847 - $317,334	35,857 New	35,857 $281,000
Q1 2021 May 13, 2021	SELL	$8.78 - $12.8 $91,312 - $133,120	-10,400 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$1.08 - $8.2 $11,232 - $85,279	10,400 New	10,400 $85,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.